- The study suggests that 5 μg of LSD is the minimum dose needed to observe subjective and performance effects, with noticeable improvements evident at 20 μg.
- Microdosing with LSD resulted in individual variation in cognitive performance, enhancing attention while also showing slower information processing on complex tasks.
- Participants reported positive mood changes alongside unwanted effects like increased anxiety or confusion, indicating a nuanced interaction between dosage and psychological outcomes.
Introduction
The research presented is the fourth publication examining the effects of low doses of LSD (lysergic acid diethylamide) in a controlled environment. The study emphasizes the growing popularity of microdosing, which involves taking a fraction of a standard psychedelic dose to potentially enhance mood and performance without significantly altering consciousness. While anecdotal evidence supports the benefits of microdosing, controlled scientific research remains limited.
Clinical Context
The researchers note that prior studies have shown substantial changes in consciousness following higher doses of LSD, typically between 100–200 μg. These effects include enhanced mental well-being and perceptual shifts. However, evidence regarding the impact of substantially lower doses is still under-explored, necessitating further investigation into microdosing and its possible cognitive and emotional benefits.
Research Design
This particular study aimed to identify the minimal effective dose of LSD affecting mood and cognition. Utilizing a double-blind, placebo-controlled, within-subject design, the researchers assessed three different LSD doses (5, 10, and 20 μg) on 24 healthy participants, all with prior experience in using psychedelics. The design ensured that each participant underwent four test sessions with at least five days between treatments.
Cognitive Assessment
Participants underwent a range of cognitive tasks designed to measure attention, information processing, and cognitive control. Tests included the Psychomotor Vigilance Task, Digit Symbol Substitution Test, and Cognitive Control Task, which collectively aimed to provide a comprehensive evaluation of how different doses of LSD impacted cognitive function.
Results Overview
Results indicated a significant interaction whereby doses of 5 and 20 μg were associated with fewer attentional lapses compared to placebo. However, the 20 μg dose did not enhance the total number of correctly encoded digits, suggesting diminished accuracy on certain tasks relative to the placebo condition. Additionally, subjective measures revealed significant variation in mood states, with participants reporting increased anxiety and confusion alongside positive mood enhancements, demonstrating a complex interplay between dose and emotional response.
Discussion and Implications
The researchers highlight the nuanced outcomes of their study, showcasing that while low doses of LSD can enhance certain mood states, they may also provoke anxiety and confusion in specific individuals. This suggests that physiological differences among participants might play a role in the variable responses to microdosing. Notably, the observed dissociation between objective measures of cognitive performance and subjective experiences could imply that participants were experiencing cognitive enhancement in attention tasks while also feeling a loss of concentration.
Future Directions
In conclusion, the authors stress the importance of further research targeting patient populations with attentional issues. By understanding the biological underpinnings of individual differences in response to low doses of LSD, future studies can illuminate therapeutic potentials for conditions such as ADHD, highlighting the need for continuous exploration into the cognitive and emotional impacts of psychedelics.
Read the full paper summary on Blossom.
